Krsnaa Diagnostics appointed two new independent directors and reappointed one, effective April 25, 2026, for two and five-year terms respectively.
The company named Chandra Prakash Singh as Interim CFO effective immediately and noted the cessation of three directors upon tenure completion.
The Board approved a comprehensive reconstitution of all five key committees, effective April 25, 2026, following the director changes.
All appointments are subject to shareholder approval via postal ballot and were made to strengthen leadership and governance.